Agreement further expands Aptar Pharma’s leading position in nasal delivery solutions and addresses significant unmet needs of delivering drugs locally over extended periods
The pet dog population alone is expected to increase from 21.4 million in 2019 to 51.5 million by 2028
Acquisition to be followed by merger; strengthens Torrent’s IPM market presence
CRL shall invest another Rs. 200 crore for creation of additional beds
Delivers robust earnings performance, successfully navigating a dynamic environment
Rising demands and advancements in eye care drive growth
New trontinemab data continue to support rapid and deep, dose-dependent reduction of amyloid plaques in Phase Ib/IIa Brainshuttle AD study
This innovative platform is strategically essential to developing and scaling high-value life sciences use cases such as streamlining the content supply chain
The safety profile of Opdualag observed in this analysis was consistent with the known profiles of nivolumab and relatlimab
Subscribe To Our Newsletter & Stay Updated
